C
CellTrak
CellTrak delivers mobile phone-based automation to agencies that are no-longer intended to work with self reported info and paper processes
About CellTrak
CellTrak is a technology company specializing in home care software solutions designed to improve the efficiency and effectiveness of home healthcare services. Operating primarily in the healthcare sector, CellTrak serves home care agencies, managed care organizations, and healthcare providers. The company's core product integrates with Electronic Medical Records (EMR) systems to offer real-time patient monitoring, automated mileage and visit reporting, secure messaging, and electronic visit verification. These features enable caregivers to be more connected and better informed, thereby enhancing the quality of care delivered to patients.
CellTrak's business model revolves around a Software-as-a-Service (SaaS) platform, where clients subscribe to use the software on a recurring basis. The company generates revenue through subscription fees, which are typically based on the number of users or the volume of services provided. This model ensures a steady stream of income while allowing for scalability as the client base grows.
The market for CellTrak's services is expanding as the demand for home healthcare rises, driven by an aging population and the increasing prevalence of chronic diseases. By offering a comprehensive solution that addresses the logistical and administrative challenges of home care, CellTrak positions itself as a vital partner for healthcare providers aiming to improve patient outcomes and operational efficiency.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2004
- Headquarters
- Schaumburg, United States
- Employees
- 58
- Open positions
- None listed
- Dealroom signal
- 65.5/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Geopositioning, Verification, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2022 | — | — | Hearst | ↗ |
| EARLY VC✓Equity / VC | Jul 2017 | $11M | $44M | MK Capital · Boathouse Capital | — |
Growth signals
Latest recorded traffic for CellTrak is 280 monthly website visits, down 95.8% over the last three months. CellTrak's team declined 7.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Boathouse Capital
MK Capital
Other known investors1 additional known investor
Hearst
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about CellTrak on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CellTrak’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.